NewEdge Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Buy
5,048
+786
+18% +$68.8K ﹤0.01% 886
2026
Q1
$363K Sell
4,262
-5,731
-57% -$511K ﹤0.01% 914
2025
Q4
$790K Buy
9,993
+6,102
+157% +$478K 0.01% 697
2025
Q3
$299K Buy
+3,891
New +$332K ﹤0.01% 876
2022
Q3
Sell
-3,813
Closed -$306K 535
2022
Q2
$306K Buy
+3,813
New +$298K 0.01% 460

Other funds holding CL

NewEdge Wealth's CL Position: Q2 2026 in Review

NewEdge Wealth increased its Colgate-Palmolive (CL) stake by 18% in Q2 2026, buying an estimated $68.8K and bringing the position to 5,048 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

NewEdge Wealth first reported a position in CL in Q2 2022 and has held it in 5 quarters since. The position peaked at $790K in Q4 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • NewEdge Wealth held 5,048 shares of Colgate-Palmolive worth $463K as of Q2 2026.
  • NewEdge Wealth bought 786 Colgate-Palmolive shares in Q2 2026, an estimated $68.8K.
  • Colgate-Palmolive made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #886 holding.
  • NewEdge Wealth first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 5 quarters since.
  • NewEdge Wealth's Colgate-Palmolive position peaked at $790K in Q4 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.